Cargando…

Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro

BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholami, Yaser H., Willowson, Kathy P., Forwood, Nicholas J., Harvie, Rozelle, Hardcastle, Nicholas, Bromley, Regina, Ryu, HyunJu, Yuen, Samuel, Howell, Viive M., Kuncic, Zdenka, Bailey, Dale L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119681/
https://www.ncbi.nlm.nih.gov/pubmed/30175390
http://dx.doi.org/10.1186/s40658-018-0217-8
_version_ 1783352110115454976
author Gholami, Yaser H.
Willowson, Kathy P.
Forwood, Nicholas J.
Harvie, Rozelle
Hardcastle, Nicholas
Bromley, Regina
Ryu, HyunJu
Yuen, Samuel
Howell, Viive M.
Kuncic, Zdenka
Bailey, Dale L.
author_facet Gholami, Yaser H.
Willowson, Kathy P.
Forwood, Nicholas J.
Harvie, Rozelle
Hardcastle, Nicholas
Bromley, Regina
Ryu, HyunJu
Yuen, Samuel
Howell, Viive M.
Kuncic, Zdenka
Bailey, Dale L.
author_sort Gholami, Yaser H.
collection PubMed
description BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (EBRT) in vitro and compare cell kill responses between the two irradiation processes. RESULTS: Three human colorectal carcinoma (CRC) cell lines (HT29, HCT116, SW48) were exposed to (90)Y doses in the ranges 1–10.4 and 6.2–62.3 Gy with initial dose rates of 0.013–0.13 Gy/hr (low dose rate, LDR) and 0.077–0.77 Gy/hr (high dose rate, HDR), respectively. Results were compared to a 6-MV photon beam doses in the range from 1–9 Gy with constant dose rate of 277 Gy/hr. The cell survival parameters from the linear quadratic (LQ) model were determined. Additionally, Monte Carlo simulations were performed to calculate the average dose, dose rate and the number of hits in the cell nucleus. For the HT29 cell line, which was the most radioresistant, the α/β ratio was found to be ≈ 31 for HDR–(90)Y and ≈ 3.5 for EBRT. LDR–(90)Y resulting in insignificant cell death compared to HDR–(90)Y and EBRT. Simulation results also showed for LDR–(90)Y, for doses ≲ 3 Gy, the average number of hits per cell nucleus is ≲ 2 indicating insufficiently delivered lethal dose. For (90)Y doses [Formula: see text]  3 Gy the number of hits per nucleus decreases rapidly and falls below ≈ 2 after ≈ 5 days of incubation time. Therefore, our results demonstrate that LDR–(90)Y is radiobiologically less effective than EBRT. However, HDR–(90)Y at ≈ 56 Gy was found to be radiobiologically as effective as acute ≈ 8 Gy EBRT. CONCLUSION: These results demonstrate that the efficacy of RNT is dependent on the initial dose rate at which radiation is delivered. Therefore, for a relatively long half-life radionuclide such as (90)Y, a higher initial activity is required to achieve an outcome as effective as EBRT.
format Online
Article
Text
id pubmed-6119681
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-61196812018-09-20 Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro Gholami, Yaser H. Willowson, Kathy P. Forwood, Nicholas J. Harvie, Rozelle Hardcastle, Nicholas Bromley, Regina Ryu, HyunJu Yuen, Samuel Howell, Viive M. Kuncic, Zdenka Bailey, Dale L. EJNMMI Phys Original Research BACKGROUND: Dose rate variation is a critical factor affecting radionuclide therapy (RNT) efficacy. Relatively few studies to date have investigated the dose rate effect in RNT. Therefore, the aim of this study was to benchmark (90)Y RNT (at different dose rates) against external beam radiotherapy (EBRT) in vitro and compare cell kill responses between the two irradiation processes. RESULTS: Three human colorectal carcinoma (CRC) cell lines (HT29, HCT116, SW48) were exposed to (90)Y doses in the ranges 1–10.4 and 6.2–62.3 Gy with initial dose rates of 0.013–0.13 Gy/hr (low dose rate, LDR) and 0.077–0.77 Gy/hr (high dose rate, HDR), respectively. Results were compared to a 6-MV photon beam doses in the range from 1–9 Gy with constant dose rate of 277 Gy/hr. The cell survival parameters from the linear quadratic (LQ) model were determined. Additionally, Monte Carlo simulations were performed to calculate the average dose, dose rate and the number of hits in the cell nucleus. For the HT29 cell line, which was the most radioresistant, the α/β ratio was found to be ≈ 31 for HDR–(90)Y and ≈ 3.5 for EBRT. LDR–(90)Y resulting in insignificant cell death compared to HDR–(90)Y and EBRT. Simulation results also showed for LDR–(90)Y, for doses ≲ 3 Gy, the average number of hits per cell nucleus is ≲ 2 indicating insufficiently delivered lethal dose. For (90)Y doses [Formula: see text]  3 Gy the number of hits per nucleus decreases rapidly and falls below ≈ 2 after ≈ 5 days of incubation time. Therefore, our results demonstrate that LDR–(90)Y is radiobiologically less effective than EBRT. However, HDR–(90)Y at ≈ 56 Gy was found to be radiobiologically as effective as acute ≈ 8 Gy EBRT. CONCLUSION: These results demonstrate that the efficacy of RNT is dependent on the initial dose rate at which radiation is delivered. Therefore, for a relatively long half-life radionuclide such as (90)Y, a higher initial activity is required to achieve an outcome as effective as EBRT. Springer International Publishing 2018-09-03 /pmc/articles/PMC6119681/ /pubmed/30175390 http://dx.doi.org/10.1186/s40658-018-0217-8 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research
Gholami, Yaser H.
Willowson, Kathy P.
Forwood, Nicholas J.
Harvie, Rozelle
Hardcastle, Nicholas
Bromley, Regina
Ryu, HyunJu
Yuen, Samuel
Howell, Viive M.
Kuncic, Zdenka
Bailey, Dale L.
Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title_full Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title_fullStr Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title_full_unstemmed Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title_short Comparison of radiobiological parameters for (90)Y radionuclide therapy (RNT) and external beam radiotherapy (EBRT) in vitro
title_sort comparison of radiobiological parameters for (90)y radionuclide therapy (rnt) and external beam radiotherapy (ebrt) in vitro
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119681/
https://www.ncbi.nlm.nih.gov/pubmed/30175390
http://dx.doi.org/10.1186/s40658-018-0217-8
work_keys_str_mv AT gholamiyaserh comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT willowsonkathyp comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT forwoodnicholasj comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT harvierozelle comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT hardcastlenicholas comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT bromleyregina comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT ryuhyunju comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT yuensamuel comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT howellviivem comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT kunciczdenka comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro
AT baileydalel comparisonofradiobiologicalparametersfor90yradionuclidetherapyrntandexternalbeamradiotherapyebrtinvitro